https://www.vaxinano.com/titre-1/2026-04-17T14:10:43+00:00https://www.vaxinano.com/ocular-toxoplasmosis/2026-04-17T14:13:07+00:00https://www.vaxinano.com/titre-3/2024-08-09T13:27:04+00:00https://www.vaxinano.com/titre-4/2026-04-17T14:14:18+00:00https://www.vaxinano.com/pairi-daiza/2026-04-21T13:04:57+00:00https://www.vaxinano.com/stellar-np-publication/2026-07-16T12:36:16+00:00https://www.vaxinano.com/safety/2024-09-10T11:38:24+00:00https://www.vaxinano.com/non-human-primate-vaccination/2026-07-16T12:36:47+00:00https://www.vaxinano.com/canine-laishmaniasis/2024-09-09T14:36:28+00:00https://www.vaxinano.com/nasal-flu-vaccination/2024-09-09T14:23:20+00:00https://www.vaxinano.com/nasal-flu-vaccine-2/2024-09-09T14:38:41+00:00https://www.vaxinano.com/sheep-toxoplasmosis/2024-09-10T11:35:36+00:00https://www.vaxinano.com/congenital-toxoplasmosis-vaccine/2024-09-10T11:48:16+00:00https://www.vaxinano.com/creation/2026-04-17T14:07:09+00:00https://www.vaxinano.com/lesechos/2026-04-21T13:05:54+00:00https://www.vaxinano.com/challenges-press/2026-04-21T13:05:42+00:00https://www.vaxinano.com/latribune/2026-04-21T13:05:21+00:00https://www.vaxinano.com/video-vaxinano-stellar-np/2026-04-21T13:03:35+00:00https://www.vaxinano.com/vaxinano-secures-funding-to-advance-nasal-vaccines/2026-04-17T14:14:43+00:00https://www.vaxinano.com/exclusive_licence_vetoquinol/2026-07-16T13:05:30+00:00https://www.vaxinano.com/th1-th17-t-cell-response/2026-07-16T13:47:43+00:00https://www.vaxinano.com/human-t-cell-activation-with-toxoplasma-gondii-antigens/2026-07-16T12:35:50+00:00https://www.vaxinano.com/enhance-the-infection-of-epithelial-cells/2026-07-16T12:34:40+00:00https://www.vaxinano.com/nanovaccine-boosts-memory-response/2026-07-16T12:33:51+00:00https://www.vaxinano.com/brouillon-autot-cell-activation-of-toxoplasma-gondii-positive-donors/2026-07-16T12:33:15+00:00https://www.vaxinano.com/techforfuture/2026-05-07T07:56:31+00:00https://www.vaxinano.com/retrospective/2026-07-17T13:24:11+00:00https://www.vaxinano.com/vaxinano-receives-france-2030-innovation-support/2026-07-16T09:21:21+00:00https://www.vaxinano.com/pioneering-inactivated-in-ovo-vaccination-for-avian-colibacillosis/2026-07-16T13:34:40+00:00https://www.vaxinano.com/vaxinano-shares-latest-vaccine-immunology-advances-at-colloque-i3m/2026-07-16T12:10:41+00:00https://www.vaxinano.com/field-evidence-highlights-the-potential-of-vxn-toxo-against-toxoplasmosis-in-captive-wildlife/2026-07-17T07:16:33+00:00https://www.vaxinano.com/vaxinano-at-nivi-advancing-the-future-of-mucosal-vaccines-through-airway-immunity/2026-07-16T12:39:13+00:00https://www.vaxinano.com/vaxinano-and-eco-animal-health-sign-exclusive-licensing-agreement-for-toxoplasmosis-vaccine/2026-08-13T07:16:26+00:00https://www.vaxinano.com/new-study-confirms-cross-strain-t-cell-immunity-induced-by-vxn-toxo/2026-09-04T07:21:27+00:00https://www.vaxinano.com/vaxinano-targets-industrialization-with-a-e10m-fundraise/2026-09-07T06:56:35+00:00